In vitro production of synthetic viral RNAs and their delivery into mammalian cells and the application of viral RNAs in the study of innate interferon responses
- PMID: 31682923
- DOI: 10.1016/j.ymeth.2019.10.013
In vitro production of synthetic viral RNAs and their delivery into mammalian cells and the application of viral RNAs in the study of innate interferon responses
Abstract
Mammalian cells express different types of RNA molecules that can be classified as protein coding RNAs (mRNA) and non-coding RNAs (ncRNAs) the latter of which have housekeeping and regulatory functions in cells. Cellular RNAs are not recognized by cellular pattern recognition receptors (PRRs) and innate immunity is not activated. RNA viruses encode and express RNA molecules that usually differ from cell-specific RNAs and they include for instance 5'capped and 5'mono- and triphosphorylated RNAs, small viral RNAs and viral RNA-protein complexes called vRNPs. These molecules are recognized by certain members of Toll-like receptor (TLR) and RIG-I-like receptor (RLR) families leading to activation of innate immune responses and the production of antiviral cytokines, such as type I and type III interferons (IFNs). Virus-specific ssRNA and dsRNA molecules that mimic the viral genomic RNAs or their replication intermediates can efficiently be produced by bacteriophage T7 DNA-dependent RNA polymerase and bacteriophage phi6 RNA-dependent RNA polymerase, respectively. These molecules can then be delivered into mammalian cells and the mechanisms of activation of innate immune responses can be studied. In addition, synthetic viral dsRNAs can be processed to small interfering RNAs (siRNAs) by a Dicer enzyme to produce a swarm of antiviral siRNAs. Here we describe the biology of RNAs, their in vitro production and delivery into mammalian cells as well as how these molecules can be used to inhibit virus replication and to study the mechanisms of activation of the innate immune system.
Keywords: Dendritic cells (DCs); DsiRNA; In vitro RNA production; Innate immunity; Interferon (IFN) response; RNA; RNA delivery; Virus.
Copyright © 2019 Elsevier Inc. All rights reserved.
Similar articles
-
RNA-based viral immunity initiated by the Dicer family of host immune receptors.Immunol Rev. 2009 Jan;227(1):176-88. doi: 10.1111/j.1600-065X.2008.00722.x. Immunol Rev. 2009. PMID: 19120484 Free PMC article. Review.
-
The RIG-I-like receptor LGP2 inhibits Dicer-dependent processing of long double-stranded RNA and blocks RNA interference in mammalian cells.EMBO J. 2018 Feb 15;37(4):e97479. doi: 10.15252/embj.201797479. Epub 2018 Jan 19. EMBO J. 2018. PMID: 29351913 Free PMC article.
-
Efficient Inhibition of Avian and Seasonal Influenza A Viruses by a Virus-Specific Dicer-Substrate Small Interfering RNA Swarm in Human Monocyte-Derived Macrophages and Dendritic Cells.J Virol. 2019 Feb 5;93(4):e01916-18. doi: 10.1128/JVI.01916-18. Print 2019 Feb 15. J Virol. 2019. PMID: 30463970 Free PMC article.
-
Caenorhabditis elegans RIG-I Homolog Mediates Antiviral RNA Interference Downstream of Dicer-Dependent Biogenesis of Viral Small Interfering RNAs.mBio. 2017 Mar 21;8(2):e00264-17. doi: 10.1128/mBio.00264-17. mBio. 2017. PMID: 28325765 Free PMC article.
-
Processing of double-stranded RNA in mammalian cells: a direct antiviral role?J Interferon Cytokine Res. 2014 Jun;34(6):469-77. doi: 10.1089/jir.2014.0003. J Interferon Cytokine Res. 2014. PMID: 24905204 Review.
Cited by
-
Utilization of Bacteriophage phi6 for the Production of High-Quality Double-Stranded RNA Molecules.Viruses. 2024 Jan 22;16(1):166. doi: 10.3390/v16010166. Viruses. 2024. PMID: 38275976 Free PMC article. Review.
-
Editorial for "Methods to characterize virus small RNAs and RNA structures".Methods. 2020 Nov 1;183:1-3. doi: 10.1016/j.ymeth.2020.10.007. Epub 2020 Oct 16. Methods. 2020. PMID: 33069799 Free PMC article. No abstract available.
-
Filovirus VP24 Proteins Differentially Regulate RIG-I and MDA5-Dependent Type I and III Interferon Promoter Activation.Front Immunol. 2022 Jan 5;12:694105. doi: 10.3389/fimmu.2021.694105. eCollection 2021. Front Immunol. 2022. PMID: 35069519 Free PMC article.
-
Immune response and potential therapeutic strategies for the SARS-CoV-2 associated with the COVID-19 pandemic.Int J Biol Sci. 2022 Feb 14;18(5):1865-1877. doi: 10.7150/ijbs.66369. eCollection 2022. Int J Biol Sci. 2022. PMID: 35342348 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical